Leadership change

CMR Surgical (CMR or ‘the Company’), the global surgical robotics business, today announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.

Massimiliano originally joined CMR as Chief Commercial Officer in 2023, helping to drive growth in installed base and bring Versius to more hospitals around the world. Today, Versius has been used to perform over 26,000 robotic-assisted minimally invasive surgeries globally.

Massimiliano joined from Evercare Group, a leading hospital group, where he served as Group Chief Executive Officer and Board member. In this role, he oversaw 30 hospitals, 16 clinics, and over 100 diagnostic centers. He brings more than 30 years of senior healthcare leadership experience having held senior executive roles for Johnson & Johnson (J&J) and Smith & Nephew. At Johnson & Johnson, Massimiliano, amongst several roles, was responsible for all Medical Device Companies within the Central Eastern Europe and Emerging Markets regions.

Supratim Bose has brought to CMR significant experience in the MedTech industry, supporting the business on its journey to bring minimal access surgery to more patients around the world. Supratim will continue to bring his extensive MedTech experience to serve CMR in his role on the Board.

Dan Moore, Chairman at CMR Surgical commented: “I am pleased to welcome Massimiliano in his new role as Interim CEO. Given his significant MedTech leadership experience, and passion for CMR and the surgical robotics industry, we are pleased to have someone of his stature take over the leadership of CMR. We look forward to working closely with Massimiliano to help CMR transform surgery for patients around the world as we open new markets and launch further Versius product advancements. As a Board, we continue to support CMR for the long-term to ensure the Company can reach its full potential. I would like to thank Supratim for his extensive contributions to CMR as CEO, and we look forward to continuing to work with him on the Board.”

Massimiliano Colella, Interim Chief Executive Officer at CMR Surgical commented: “I am honoured to lead CMR and make sure we can seize our opportunity to offer hospitals and patients choice when deciding to start a surgical robotics programme. I have worked for large medical device businesses, and a hospital group, but this is a truly unique opportunity to lead a Company that has exceptional people, and an excellent product. Having conducted over 26,000 procedures, the value of Versius as a compact, digitally driven system has been demonstrated globally and gives us an excellent base to build on from here. We will always continue to focus on our customers, and by doing so I am confident that CMR and Versius will be able to achieve its mission of transforming surgery for patients around the world.”

Supratim Bose, Outgoing CEO and Vice-Chairman of the Board at CMR Surgical commented: “I have worked with reputed organisations in the MedTech industry for over four decades and I can say it has been a privilege to lead the CMR organisation. It is now time for me to transition into a Board role as Vice-Chairman of the CMR Board, and Massimiliano is the best person to take over my responsibility. I am pleased that we have someone of his calibre to lead the business as we continue our growth journey. With Massimiliano leading the business, a disruptive product, and exceptional people in the business, I am confident that CMR can transform surgery for good for all surgeons and patients around the world.”

ENDS

The Versius Surgical Robotic System

Versius resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.

Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.

But it’s more than just a robot. Versius captures meaningful data with its wider digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

About CMR Surgical Limited

CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius, a next-generation surgical robot.

Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base.